Treatment with mesenchymal stem cells downregulates pro-fibrotic long noncoding RNAs
Mesenchymal stem cell (MSC) therapy shows promise in fibrosis treatment. This article analyzes how MSCs downregulate pro-fibrotic long noncoding RNAs (lncRNAs), offering insights into their antifibrotic mechanism and potential therapeutic applications. Explore the detailed findings within.